High blood pressure in the doctor’s clinic may not predict heart risks. Round-the-clock blood pressure measurements, especially those during the night, are better predictors of major cardiovascular problems. – Continuously measuring blood pressure may help predict heart disease and related deaths among individuals with treatment-resistant hypertension, while blood pressure readings taken in a medical clinic do not appear to predict future heart risks, according to a report in November 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Diabetes medications (rosiglitazone – Avandia) in same class carry different risks of heart failure, death – Older adults who take the diabetes medication rosiglitazone appear to have a higher risk of death and heart failure than those taking the related medication pioglitazone, according to a report in the November 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Bicuspid aortic valve is the most common congenital cardiac anomaly in the adult population, and these adults do not appear to have lower survival rates compared to the general population. – Young adults with a bicuspid aortic valve, a congenital heart abnormality, experience subsequent cardiac events but do not appear to have lower survival rates compared to the general population, according to a study in the September 17 issue of the Journal of the American Medical Association (JAMA).
A new drug telmisartan is as effective as the popular drug ramipril in reducing cardiovascular death in high risk patients and it has fewer side effects. – A major Canadian-led global study has found that a new blood pressure medication is effective in reducing cardiovascular death, with fewer side effects than the current standard of care. The study found a new drug telmisartan is as effective as the popular drug ramipril in reducing cardiovascular death in high risk patients and it has fewer side effects.
Cardiac effects associated with breast cancer treatment appear lower with dose-dense delivery of conventional chemotherapy – A new pilot study by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) found that breast cancer patients can be treated safely with a “dose-dense” regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin), a drug that has previously been shown to cause cardiac toxicity.
Special issue of JACC features intriguing link between statins and Atrial Fibrillation (AF) prevention, tools to ensure the highest-quality AF care, and more. – When we’re young, a racing heart often means love is in the air. If you’re a “baby boomer,” it might mean you’ve just joined the 2.2 million Americans who have atrial fibrillation (AF), an irregularity in the heart’s rhythm that grows more common as we age and markedly increases the risk for stroke.
Hospital quality gap persists, resulting in 171,424 preventable deaths, according to HealthGrades’ Sixth Annual Hospital Quality and Clinical Excellence study. – Patients treated at top-rated hospitals in US are nearly one-third less likely to die, on average, than those admitted to all other hospitals, according to a study released by HealthGrades (Nasdaq: HGRD), the leading independent healthcare ratings organization.
The burden of financing and providing medical care for persons older than 65 in the United States having diagnosed diabetes is growing rapidly as a result of increased incidence and, especially, prevalence of diagnosed diabetes, decreased mortality, and overall lack of improvement in rates of complications in persons having diagnosed diabetes. – The prevalence of diabetes mellitus is growing worldwide. Consequently, there has been increased emphasis on primary and secondary prevention of diabetes. The annual number of Americans older than 65 newly diagnosed with diabetes increased by 23 percent between 1994 to 1995 and 2003 to 2004, according to a report in the January 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
The ability to change or modulate the patient?s immune response has now been shown to be attainable as well as successful in treating certain stages of heart failure. – Modifying the immune system of a patient with heart failure reduces the patient’s risk of death and the need for hospitalization, according to research published in recent edition of The Lancet.
Vitamin D deficiency is associated with incident cardiovascular disease. Further clinical and experimental studies may be warranted to determine whether correction of vitamin D deficiency could contribute to the prevention of cardiovascular disease. – The same vitamin D deficiency that can result in weak bones now has been associated with an increased risk of cardiovascular disease, Framingham Heart Study researchers report in Circulation: Journal of the American Heart Association.